Pharmacological vitamin c inhibits mtor signaling and tumor growth by degrading rictor and inducing hmox1 expression

HIGHLIGHTS

• who: Senlin Qin and colleagues from the College of Animal Science and Technology, Northwest AandF University, Yangling, Shaanxi, China have published the paper: Pharmacological vitamin C inhibits mTOR signaling and tumor growth by degrading Rictor and inducing HMOX1 expression, in the Journal: (JOURNAL) of January/21,/2023
• what: The results of the study showed that STF-31, a GLUT1 inhibitor, did not affect the ability of pharmacological VC to inhibit mTOR activation (S3G and S3H Fig). The study investigated that VC treatment induced autophagy and, thus, inhibited cancer cells viability, which may play a role . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.